Imaging of Clear Cell Renal Carcinoma with Immune Checkpoint Targeting Aptamer-Based Probe.
- DOI
- 10.3390/ph15060697
- Published
- 2022 Jun 1
- Container
- Pharmaceuticals (Basel, Switzerland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/ph15060697,
title = {Imaging of Clear Cell Renal Carcinoma with Immune Checkpoint Targeting Aptamer-Based Probe.},
author = {Malicki S and Pucelik B and Żyła E and Benedyk-Machaczka M and Gałan W and Golda A and Sochaj-Gregorczyk A and Kamińska M and Encarnação JC and Chruścicka B and Marti HP and Chen TJ and Magiera-Mularz K and Zięba B and Holak TA and Dąbrowski JM and Czarna A and Kozieł J and Mydel P and Dubin G},
year = {2022},
journal = {Pharmaceuticals (Basel, Switzerland)},
doi = {10.3390/ph15060697},
url = {https://doi.org/10.3390/ph15060697}
}RIS
TY - JOUR TI - Imaging of Clear Cell Renal Carcinoma with Immune Checkpoint Targeting Aptamer-Based Probe. AU - Malicki S AU - Pucelik B AU - Żyła E AU - Benedyk-Machaczka M AU - Gałan W AU - Golda A AU - Sochaj-Gregorczyk A AU - Kamińska M AU - Encarnação JC AU - Chruścicka B AU - Marti HP AU - Chen TJ AU - Magiera-Mularz K AU - Zięba B AU - Holak TA AU - Dąbrowski JM AU - Czarna A AU - Kozieł J AU - Mydel P AU - Dubin G PY - 2022 JO - Pharmaceuticals (Basel, Switzerland) DO - 10.3390/ph15060697 UR - https://doi.org/10.3390/ph15060697 ER -
APA
S, M., B, P., E, Ż., M, B., W, G., A, G., A, S., M, K., JC, E., B, C., HP, M., TJ, C., K, M., B, Z., TA, H., JM, D., A, C., J, K., P, M., & G, D. (2022). Imaging of Clear Cell Renal Carcinoma with Immune Checkpoint Targeting Aptamer-Based Probe.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph15060697
Source records
- pubmed · retrieved 2026-09-25T00:06:54.545Z